Other OTC - Delayed Quote USD

Cannabis Sativa, Inc. (CBDS)

0.0170 +0.0007 (+4.29%)
At close: April 18 at 2:23 PM EDT
Loading Chart for CBDS
DELL
  • Previous Close 0.0163
  • Open 0.0163
  • Bid --
  • Ask --
  • Day's Range 0.0163 - 0.0170
  • 52 Week Range 0.0012 - 0.0550
  • Volume 111,129
  • Avg. Volume 154,729
  • Market Cap (intraday) 1.228M
  • Beta (5Y Monthly) 1.45
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0400
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Cannabis Sativa, Inc., through its subsidiaries, primarily provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. The company offers PrestoDoctor, an online telemedicine platform, which provides access to physicians for getting a medical marijuana recommendation using video conferencing technology. Its products under development include Lozenges for relief from throat irritation; Recover, a deep penetrating healing balm used to relieve pain for sore muscles, joints, arthritic, and back pain; Trauma Cream, a cream for blended infusion of cannabinoids and THC; Face Garden, an antioxidant moisturizing cream for the face; Body Garden, a moisturizing body lotion; and Lip Garden, an emollient balm. The company also offers Wild Earth Naturals and hi branded men's and women's fashion tee shirts and sweatshirts, as well as caps and coffee mugs through Website, wildearthnaturals.com; and holds intellectual property license for manufacture of medical marijuana edibles. It serves cannabidiol and marijuana industries. The company was formerly known as Ultra Sun Corporation and changed its name to Cannabis Sativa, Inc. November 2013. Cannabis Sativa, Inc. is based in Mesquite, Nevada.

6

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CBDS

Performance Overview: CBDS

Trailing total returns as of 4/18/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CBDS
0.00%
S&P 500
5.06%

1-Year Return

CBDS
57.50%
S&P 500
20.71%

3-Year Return

CBDS
97.64%
S&P 500
19.73%

5-Year Return

CBDS
99.15%
S&P 500
72.77%

Compare To: CBDS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CBDS

Valuation Measures

As of 4/18/2024
  • Market Cap

    1.23M

  • Enterprise Value

    1.43M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.66

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    1.16

  • Enterprise Value/EBITDA

    -0.99

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -137.68%

  • Return on Assets (ttm)

    -24.31%

  • Return on Equity (ttm)

    -99.85%

  • Revenue (ttm)

    1.24M

  • Net Income Avi to Common (ttm)

    -1.7M

  • Diluted EPS (ttm)

    -0.0400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    144.91k

  • Total Debt/Equity (mrq)

    33.70%

  • Levered Free Cash Flow (ttm)

    63.12k

People Also Watch